Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Repligen Corp
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Find out what a historical investment in Repligen Corp would be worth today using our RGEN stock calculator.
Market Capitalisation
$6.54B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.46M
High today
$119.01
Low today
$113.26
Open price
$116.29
52-week high
$175.77
52-week low
$109.50
Ready to start your investing journey with Stake?
Open an accountHow do I buy RGEN shares in Australia?
Buying RGEN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Repligen Corp in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RGEN
What is the ticker symbol of Repligen Corp?
The ticker symbol for Repligen Corp is RGEN.
How much is one share of RGEN?
One share of RGEN is valued at $114.01 as of 13 May 2026.
What is the market capitalisation of Repligen Corp RGEN?
As of 13 May 2026 Repligen Corp has a market cap of $6.54B.
What is the P/E ratio of RGEN?
The Price to Earnings ratio of RGEN is 124.67.
What is the Earnings Per Share of RGEN?
The Earnings Per Share of RGEN is $0.91.
What is the 52-week high for Repligen Corp stock?
The Repligen Corp 52-week high stock price is $175.77.
What is the 52-week low for Repligen Corp stock?
The Repligen Corp 52-week low stock price is $109.50.
Can I buy RGEN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RGEN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RGEN on Stake
- Buy RGEN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RGEN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RGEN related stocks